Trial Profile

A phase I trial assessing safety, tolerability, and pharmacokinetics of the LNK01004 ointment in healthy adults and patients with mild to moderate plaque psoriasis

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 14 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

25 May 2023 According to Lynk Pharmaceuticals media release, phase I trial in healthy subject was completed earlier this year and the results showed good safety profile.
25 May 2023 According to Lynk Pharmaceuticals media release, the company has dosed the first cohort of psoriatic patients in this trial.
03 Aug 2022 According to Lynk Pharmaceuticals media release, the company has completed dosing of the first cohort of participants in this study in late July, 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com